Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Carballo

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Preventive Cardiology|October 23, 2025
Relationship of the Healthy Diet Characteristics Recommended by the 2021 ESC Guidelines with Vascular Events in Patients with Established CVDL L F Hoes, J M Geleijnse, F Mach, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2025
The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemiaChristian Sordo-Bahamonde, Alejandra Martínez-Pérez, Rocío Granda-Díaz, et al.
Plos One|February 22, 2019
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare interventionDavid Carballo, Nicolas Rodondi, Reto Auer, et al.
European Journal of Clinical Investigation|April 3, 2019
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromesBaris Gencer, Fabio Rigamonti, David Nanchen, et al.
European Journal of Preventive Cardiology|November 23, 2023
Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndromeElena Tessitore, Mattia Branca, Dik Heg, et al.
Swiss Medical Weekly|August 14, 2022
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after studyLauriane Gilgien-Dénéréaz, Julian Jakob, Kali Tal, et al.
Journal of the American Heart Association|October 8, 2021
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary SyndromesRoland Klingenberg, Soheila Aghlmandi, Lorenz Räber, et al.
Atherosclerosis|February 1, 2021
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse eventsRoland Klingenberg, Soheila Aghlmandi, Baris Gencer, et al.
European Journal of Preventive Cardiology|March 23, 2021
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelinesKonstantinos C Koskinas, Baris Gencer, David Nanchen, et al.
European Heart Journal. Acute Cardiovascular Care|April 21, 2017
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohortSoheila Aghlmandi, Nadine Schärer, Dik Heg, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Preventive Cardiology|October 23, 2025
Relationship of the Healthy Diet Characteristics Recommended by the 2021 ESC Guidelines with Vascular Events in Patients with Established CVDL L F Hoes, J M Geleijnse, F Mach, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 14, 2025
The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemiaChristian Sordo-Bahamonde, Alejandra Martínez-Pérez, Rocío Granda-Díaz, et al.
Plos One|February 22, 2019
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare interventionDavid Carballo, Nicolas Rodondi, Reto Auer, et al.
European Journal of Clinical Investigation|April 3, 2019
Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromesBaris Gencer, Fabio Rigamonti, David Nanchen, et al.
European Journal of Preventive Cardiology|November 23, 2023
Drinking patterns of alcohol and risk of major adverse cardiovascular events after an acute coronary syndromeElena Tessitore, Mattia Branca, Dik Heg, et al.
Swiss Medical Weekly|August 14, 2022
Long-term effects of systematic smoking cessation counselling during acute coronary syndrome, a multicentre before-after studyLauriane Gilgien-Dénéréaz, Julian Jakob, Kali Tal, et al.
Journal of the American Heart Association|October 8, 2021
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary SyndromesRoland Klingenberg, Soheila Aghlmandi, Lorenz Räber, et al.
Atherosclerosis|February 1, 2021
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse eventsRoland Klingenberg, Soheila Aghlmandi, Baris Gencer, et al.
European Journal of Preventive Cardiology|March 23, 2021
Eligibility for PCSK9 inhibitors based on the 2019 ESC/EAS and 2018 ACC/AHA guidelinesKonstantinos C Koskinas, Baris Gencer, David Nanchen, et al.
European Heart Journal. Acute Cardiovascular Care|April 21, 2017
Thrombus aspiration in acute coronary syndromes: prevalence, procedural success, change in serial troponin T levels and clinical outcomes in a contemporary Swiss cohortSoheila Aghlmandi, Nadine Schärer, Dik Heg, et al.
Pageof 10